MedTech News
FDA clears Amber Implants’ vertebral augmentation system
The company is working to obtain CE marking of the system in the European Union.
OrganOx gets FDA green light for liver perfusion during air transport
OrganOx announced today that it received FDA approval for the use of its normothermic machine perfusion (NMP) device during air transport.
3D bioprinted mini placentas could transform pregnancy research
By 3D bioprinting miniature placentas, scientists have provided a new way to study complications in pregnancy, with the research led by the University of Technology Sydney (UTS).
AI can predict complications from surgery better than doctors
A new artificial intelligence model found previously undetected signals in routine heart tests that strongly predict which patients will suffer potentially deadly complications after surgery. The model significantly outperformed risk scores currently relied upon by doctors.
Hot flashes can be reliably predicted by an AI-driven algorithm, study shows
University of Massachusetts Amherst researchers and scientists at Embr Labs, a Boston-based start-up, have developed an AI-driven algorithm that can accurately predict nearly 70% of hot flashes before they’re perceived.
New way of detecting tumor DNA in urine can identify bladder cancer
Researchers from the University of Birmingham’s Bladder Cancer Research Center have used a new method to detect chemical changes in the DNA in an individual’s urine sample; epigenetic changes, called methylation.
Implantable neurostimulation system restores blood pressure balance after spinal cord injury
Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs. In 2022, Krebs experienced a severe spinal cord injury (SCI) in a motor vehicle accident. Since that time, Krebs requires the use of a wheelchair.
Gene editing may represent a new way to treat inherited kidney disease
Researchers in Berlin have used base editing to repair mutations that cause the kidney disorder ADPKD in cells from both mice and humans. In mice, a team led by Michael Kaminski was able to ease a key symptom of the difficult-to-treat disease.